Saturday, July 12, 2025

Latest

BMO Upgrades Cineplex Price Target To $7.00, Rating To Market Perform

On Friday, Cineplex Inc (TSX: CGX) reported their third quarter results. Cineplex’s revenue was $61 million compared to 2019 third quarter’s revenue of $418.4 million, and while the reported loss per share came in at $1.91. They also announced that their financial covenant suspension will be extended until the second quarter of 2021 and that there was $460 million outstanding under credit facilities.

BMO Capital Markets released a note today, increasing its 12-month price target and rating on Cineplex. They now have a C$7 price target and market perform ratings, up from C$6 and underperform. Tim Casey, BMO’s analyst, comments, “encouraging developments regarding vaccines provide incremental optimism that consumers will return to theatres next year.” Although he accepts that a “return to normal” scenario is a much longer-term thought, the excellent vaccine data reduced what he calls a “value-destroying liquidity event.”

Casey expects financials will remain weak in the fourth quarter, “given current pandemic realities regarding closures in much of Canada and a lack of new product from Hollywood,” and that everything, “hinges on a recovery from the pandemic,” in 2021.

Casey calls the new credit agreement with lenders a favorable scenario and believes Cineplex must generate between C$27 and C$30 million in annualized EBITDA in 2021 to clear the covenant test next year. He adds, “A liquidity test of a minimum $100mm through 1/31/21 seems to be a much easier bar to reach.” He forecasts that in the second quarter of 2021, cash burn improves to being flat while the business operates at 50% revenue compared to the same quarter in 2019.

He adds that they expect the industry to recover to a sustainable level that is lower than pre-COVID levels and says, “Longer-term challenges remain.” He adds that he believes COVID just accelerated the industry’s headwinds from the demand and supply side.

With the price target and rating increase, BMO raised its 2020 and 2021 estimates, which can be seen below.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Mergers Set the Stage for Uranium’s Growth Cycle | Forum-Baselode Merger

The Goal is Gold Production as Soon as Possible! | Gordon Robb – ESGOLD Corp.

Snowline Gold: The Multi Billion Dollar Valley PEA

Recommended

First Majestic Produces 7.9 Silver Equivalent Ounces In Q2, Lifts Production Guidance

Antimony Resources Drills 4.17% Antimony Over 7.4 Metres At Bald Hill

Related News

DraftKings: Consensus Estimates For Q1 2021

DraftKings (NASDAQ: DKNG) will be reporting its first quarter financial results on May 7th before...

Thursday, May 6, 2021, 05:17:00 PM

Organigram: Consensus Analyst Estimates For Q2 2021

Organigram Holdings (TSX: OGI) (NASDAQ: OGI) will be reporting their fiscal second quarter on April...

Saturday, April 10, 2021, 01:35:00 PM

New Found Gold: BMO Initiates With $10 Price Target

BMO Capital Markets this week initiated coverage on New Found Gold (TSXV: NFG) with an...

Thursday, June 9, 2022, 11:02:00 AM

Chipotle: First Quarter Analyst Consensus Estimates

Chipotle Mexican Grill (NYSE: CMG) will be reporting their first quarter on April 21st after...

Sunday, April 18, 2021, 04:57:00 PM

Snap: Analysts Call For Company To Hit Guidance For Q1

Snap Inc (NYSE: SNAP) will be reporting their first quarter on April 22nd after market...

Tuesday, April 20, 2021, 04:04:00 PM